药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Hexachlorophene
Felbamate
The risk or severity of QTc prolongation can be increased when Felbamate is combined with Chlorpheniramine.
Hexachlorophene
Ketotifen
The risk or severity of QTc prolongation can be increased when Ketotifen is combined with Chlorpheniramine.
Hexachlorophene
Terbutaline
The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Chlorpheniramine.
Hexachlorophene
Brompheniramine
The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Chlorpheniramine.
Hexachlorophene
Rosoxacin
The risk or severity of QTc prolongation can be increased when Rosoxacin is combined with Chlorpheniramine.
Hexachlorophene
Indapamide
The risk or severity of QTc prolongation can be increased when Indapamide is combined with Chlorpheniramine.
Hexachlorophene
Emedastine
The risk or severity of QTc prolongation can be increased when Emedastine is combined with Chlorpheniramine.
Hexachlorophene
Levacetylmethadol
The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Levacetylmethadol.
Hexachlorophene
Ivosidenib
The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Ivosidenib.
Hexachlorophene
Dexverapamil
The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Dexverapamil.
Hexachlorophene
Penfluridol
The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Penfluridol.
Hexachlorophene
Dexchlorpheniramine
The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Dexchlorpheniramine.
Hexachlorophene
Lorcainide
The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Lorcainide.
Hexachlorophene
Bunaftine
The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Bunaftine.
Hexachlorophene
Nizofenone
The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Nizofenone.
Hexachlorophene
Otilonium
The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Otilonium.
Hexachlorophene
Sultopride
The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Sultopride.
Hexachlorophene
Sitafloxacin
The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Sitafloxacin.
Hexachlorophene
Oxatomide
The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Oxatomide.
Hexachlorophene
Abexinostat
The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Abexinostat.